María E. Figueroa

ORCID: 0000-0003-4887-4981
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myeloid Leukemia Research
  • Epigenetics and DNA Methylation
  • Histone Deacetylase Inhibitors Research
  • Cancer-related gene regulation
  • RNA modifications and cancer
  • Acute Lymphoblastic Leukemia research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Protein Degradation and Inhibitors
  • Pluripotent Stem Cells Research
  • Cancer Genomics and Diagnostics
  • DNA Repair Mechanisms
  • Hemoglobinopathies and Related Disorders
  • Genomics and Chromatin Dynamics
  • Chronic Myeloid Leukemia Treatments
  • Immune cells in cancer
  • RNA Research and Splicing
  • Chronic Lymphocytic Leukemia Research
  • Renal and related cancers
  • RNA Interference and Gene Delivery
  • Glioma Diagnosis and Treatment
  • Phytase and its Applications
  • Genetic Syndromes and Imprinting
  • Tuberculosis Research and Epidemiology
  • Botanical Research and Applications
  • Hematopoietic Stem Cell Transplantation

University of Miami
2017-2025

Sylvester Comprehensive Cancer Center
2017-2025

George Washington University
2025

Ocean Medical Center
2025

University Medical Center
2025

Fundación Huésped
2024

Cornell University
2008-2023

Albert Einstein College of Medicine
2005-2023

Johns Hopkins Medicine
2022

Sidney Kimmel Comprehensive Cancer Center
2014-2022

Acute myeloid leukemia (AML) is a heterogeneous disease with respect to presentation and clinical outcome. The prognostic value of recently identified somatic mutations has not been systematically evaluated in phase 3 trial treatment for AML.We performed mutational analysis 18 genes 398 patients younger than 60 years age who had AML were randomly assigned receive induction therapy high-dose or standard-dose daunorubicin. We validated our findings an independent set 104 patients.We at least...

10.1056/nejmoa1112304 article EN New England Journal of Medicine 2012-03-14

DNA methylation is a chemical modification of cytosine bases that pivotal for gene regulation, cellular specification and cancer development. Here, we describe an R package, methylKit, rapidly analyzes genome-wide epigenetic profiles from high-throughput hydroxymethylation sequencing experiments. methylKit includes functions clustering, sample quality visualization, differential analysis annotation features, thus automating simplifying many the steps discerning statistically significant or...

10.1186/gb-2012-13-10-r87 article EN cc-by Genome biology 2012-10-03

The distribution of cytosine methylation in 6.2 Mb the mouse genome was tested using cohybridization genomic representations from a methylation-sensitive restriction enzyme and its methylation-insensitive isoschizomer. This assay, termed HELP ( H paII tiny fragment E nrichment by L igation-mediated P CR), allows both intragenomic profiling intergenomic comparisons methylation. profile shows most to be contiguous methylated sequence with occasional clusters hypomethylated loci, usually but...

10.1101/gr.5273806 article EN cc-by-nc Genome Research 2006-06-29

We have developed an enhanced form of reduced representation bisulfite sequencing with extended genomic coverage, which resulted in greater capture DNA methylation information regions lying outside traditional CpG islands. Applying this method to primary human bone marrow specimens from patients Acute Myelogeneous Leukemia (AML), we demonstrated that genetically distinct AML subtypes display diametrically opposed patterns. As compared normal controls, observed widespread hypermethylation IDH...

10.1371/journal.pgen.1002781 article EN cc-by PLoS Genetics 2012-06-21

Somatic mutations in IDH1/IDH2 and TET2 result impaired TET2-mediated conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC). The observation that WT1 inactivating anticorrelate with TET2/IDH1/IDH2 acute myeloid leukemia (AML) led us hypothesize may impact function. mutant AML patients have reduced 5hmC levels similar AML. These are characterized by convergent, site-specific alterations DNA hydroxymethylation, which drive differential gene expression more than promoter...

10.1016/j.celrep.2014.11.004 article EN cc-by Cell Reports 2014-12-01

Although azacitidine (AZA) improves survival in patients with high-risk myelodysplastic syndrome, the overall response remains approximately 50%. Entinostat is a histone deacetylase inhibitor that has been combined AZA significant clinical activity previous phase I dose finding study.Open label II randomized trial comparing 50 mg/m(2)/d given for 10 days ± entinostat 4 day 3 and 10. All subtypes of myelodysplasia, chronic myelomonocytic leukemia, acute myeloid leukemia myelodysplasia-related...

10.1200/jco.2013.50.3102 article EN Journal of Clinical Oncology 2014-03-25

The cytidine analogues azacytidine and 5-aza-2'-deoxycytidine (decitabine) are commonly used to treat myelodysplastic syndromes, with or without a myeloproliferative component. It remains unclear whether the response these hypomethylating agents results from cytotoxic an epigenetic effect. In this study, we address question in chronic myelomonocytic leukaemia. We describe comprehensive analysis of mutational landscape tumours, combining whole-exome whole-genome sequencing. identify average...

10.1038/ncomms10767 article EN cc-by Nature Communications 2016-02-24

Motivation: DNA methylation plays critical roles in gene regulation and cellular specification without altering sequences. The wide application of reduced representation bisulfite sequencing (RRBS) whole genome (bis-seq) opens the door to study at single CpG site resolution. One challenging question is how best test for significant differences between groups biological samples order minimize false positive findings. Results: We present a statistical analysis package, methylSig, analyse...

10.1093/bioinformatics/btu339 article EN Bioinformatics 2014-05-16

Abstract Aging is associated with functional decline of hematopoietic stem cells (HSC) as well an increased risk myeloid malignancies. We performed integrative characterization epigenomic and transcriptomic changes, including single-cell RNA sequencing, during normal human aging. Lineage−CD34+CD38− [HSC-enriched (HSCe)] undergo age-associated epigenetic reprogramming consisting redistribution DNA methylation reductions in H3K27ac, H3K4me1, H3K4me3. This aged HSCe globally targets...

10.1158/2159-8290.cd-18-1474 article EN Cancer Discovery 2019-05-13

The class II Histone deacetylase (HDAC), HDAC4, is expressed in a tissue-specific manner, and it represses differentiation of specific cell types. We demonstrate here that HDAC4 the proliferative zone small intestine colon its expression down-regulated during intestinal vivo vitro. Subcellular localization studies demonstrated was predominantly nuclear proliferating HCT116 cells relocalized to cytoplasm after cycle arrest. Down-regulating by interfering RNA (siRNA) induced growth inhibition...

10.1091/mbc.e08-02-0139 article EN Molecular Biology of the Cell 2008-07-17
Coming Soon ...